The pharmaceutical industry has long relied on cutting edge technologies to help deliver safe, reliable drugs to market. With the recent pandemic, its proved more important than ever for pharmaceutical companies to get drugs and vaccines to market faster than ever before.
Subroto Mukherjee, Head of Innovation and Emerging Technology, Americas at GlaxoSmithkline Consumer ... [+] Healthcare
Artificial intelligence and machine learning have been playing a critical role in the pharmaceutical industry and consumer healthcare business. From augmented intelligence applications such as disease identification and diagnosis, helping identify patients for clinical trials, drug manufacturing, and predictive forecasting, these technologies have proven critical. On a recent episode of the AI Today podcast Subroto Mukherjee, who is Head of Innovation and Emerging Technology, Americas at GlaxoSmithkline Consumer Healthcare discussed how AI and ML are being applied to the pharmaceutical industry and some unique use cases for AI and ML technology. In this follow up interview he shares his insights in more detail.
How is AI currently being applied in the pharmaceutical industry?
Subroto Mukherjee: AL and ML have been critical in the pharmaceutical industry and consumer healthcare business. AI and ML are playing an important role during this pandemic, driven by COVID and the race to discover effective vaccines. The top-level uses in Pharma and Consumer Healthcare arena as follows:
Apart from the Healthcare conditions, we see many AI ML usage in Digital Transformation areas for Pharma and Healthcare companies such as Martech, AdTech, Supply Chain, Sales, and Customer Service.
What are some unique use cases for AI and ML technology in the pharmaceutical industry?
Subroto Mukherjee: As per the article in guardian-Artificial intelligence group,DeepMindhas cracked a serious scientific problem that has stumped researchers for half a century. AlphaFold, the company and research laboratory using the AI program, showed it could predict how proteins fold into 3D shapes. The advantage of this discovery is that it will help researchers discover the mechanisms that drive some diseases and pave the way for - designer medicines, more nutritious crops, and "green enzymes" that can break down plastic pollution.
Another unique case and my favorite and involved in enabling the GSK consumer R&D team is AI in Sensory Science. AI and ML are ramping up predicting parameters in foods, beverages, agriculture, andmedicine. This could lead to hyper-personalized products for food, beverage, and medicines customized for different demographics and ethnicities; we extensively usesensoryproperties beyond taste, such as smell, appearance, and texture, influencing what we select to eat or drink.
Can you share use cases where AI was successfully applied at GlaxoSmithKline?
Subroto Mukherjee: Let me share some use cases in our consumer healthcare line of business.
Predictive Forecasting:We have popular seasonal brands in the Allergy and Cold and Flu category. The business use case is to have a predictive model that predicts how the upcoming season for allergy or cold and flu would shape up in different regions, and when are the predicted peaks and troughs. The advantage of this information is to inform consumers on our brand.com website, improve our national and regional media delivery and inform retailers of seasonal activation timing (distribution, stock up, display and secondary support).
Sensory Models Humans react differently, to taste, size, texture, color, and Sensory AI models help in a holistic way of understanding, predicting, and optimizing consumer preference. We use multiple parameters, such as taste, texture, color, and ML models, to understand the relationship between the consumer and the desired product experience. Our brands offer gummies, tablets, and liquids for our over-the-counter products, and these models are beneficial.
AI in eye-tracking:We do studies with our consumers and retailers in our shoppers science lab and monitor how they look at our products while they shop online or in stores. Consumers and retail teams with consent in our labs wear eye-tracking glasses and look at the products on shelf or online. During this process, images are captured and analyzed using AI. The analysis includes Areas of Interest (AOI) metrics, including the time to first fixation and time spent, gaze plots, heatmaps, and video replays. This helps in better product placement, improves our art and labeling, and helps us understand consumer behavior.
What are some of the challenges to AI adoption at larger organizations?
Subroto Mukherjee: Key challenges to AI adoption at larger organizations are as follows:
What are some of the challenges around data privacy, security, ethics, and transparency that organizations such as GSK are dealing with?
Subroto Mukherjee: Data privacy and security are of the highest importance for our organization. We constantly ensure all data privacy, security laws are followed, and appropriate training is provided across our different portfolios and adhered to by our partners and complementary workers. Data classification (PII, CSI, Sensitive), adherence of our systems, and processes to the GDPR or California privacy rights act's needs are some of the challenges we constantly face.
For AI ethics and transparency, we make sure MLOps processes are in place, and Machine learning (ML) models model scoring is established, monitoring and drift detection, the feedback loop is transparently followed. We bring a diverse ML team with diverse experience embedded in the team and test the models constantly to bring transparency and remove bias from the Machine learning models.
The global pandemic has really shaken up the pharma industry. How are you seeing AI and machine learning being put to use in the fight against the pandemic?
Subroto Mukherjee: Concerning the pandemic the biggest use of AI and machine learning from my understanding is to tease out COVID's biological secrets and identify the few molecules which will help end COVID among the millions and to reduce the time to market drugs either be discovery, development to clinical trials and final FDA approvals. Look at the speed and agility of the current vaccine it took 300 days from identifying the coronavirus genome to the first vaccine study, which has previously taken an average of eight to ten years.
Medical Mining - Let me focus on one specific initiative - "US White House - Call to Action." to analyze and Transform COVID-19 Data into Clinical Knowledge. White House is partnering with the AI research community to understand the novel coronavirus by mining medical literature. Natural language processing is one of the fastest-growing practices in this area, helping with this initiative. Medical imaging companies using AI and ML claimed record-level accuracy in detecting covid-induced pneumonia from CT scans, despite concerns from some stakeholders on the quality of training data.
Another important impact of COVID-19 is the impact of the supply chain. All companies, including ours, are facing the impact of COVID in the supply chain and manufacturing. Be it the supply of raw material or distribution of finished goods, it helps in pre-empting the risks associated with it. Companies are scrambling to respond to rapidly shifting consumer demand, limited supply of some products, and new workplace rules. AI and ML are used in Planning and Forecasting, Bots for automation and collaboration, and many key areas of the value chain.
How do large organizations approach change management for transformative technologies such as AI?
Subroto Mukherjee: We are implementing agile transformation across the business to create an effective and simple change management structure. Our technology organization, business team, and leadership team have undergone agile training. The change management discipline has been re-oriented with a clear hierarchy of approvals (key decision-makers) for onboarding new AI technology solutions. We define clear business objectives and value for now, next, and later for these transformative technologies.
What do you see as critical needs for workforce development around AI?
Subroto Mukherjee: We need reskilling and education among the workforce, not only in technical aspects but also in AI's business value. AI for Good or AI ethics is another key aspect that employees and the business community need to understand. Workers should not be afraid of AI, but rather embrace it and understand the benefits of AI. In terms of workforce, organizations need to scale up slowly with monitored results and a pool of data scientists knowing the business, data engineers, and subject matter experts.
How is the global regulatory environment impacting the pharma industrys adoption of AI?
Subroto Mukherjee: It is necessary to meet compliance and regulatory requirements as regulators need to safeguard consumers, and it does impact the timelines of new AI solutions to be rolled out. But organizations should be collaborating with regulators to streamline this process to the benefit of all. Both regulators and pharma companies can embrace AI and other digital transformation initiatives to drive the economy, cost efficiency, and value-driven effectiveness of regulatory operations.
What AI technologies are you most looking forward to in the coming years?
Subroto Mukherjee: I am looking forward to the advancement and extended use of Natural language processing, Robotics, Speech, and computer vision in the coming years.
See the rest here:
The Increasing Use Of AI In The Pharmaceutical Industry - Forbes
- Oncology Precision Medicine Market Research, Industry Trends and Global Forecasts, 2035 - Rising Partnership and ... - PR Newswire - March 18th, 2024
- 3 Precision Medicine Stocks That Could Benefit From the Industry's Rise - InvestorPlace - March 18th, 2024
- Prime Editing Approach Provides a Faster, More Effective Way to Screen for Cancer Mutations - Inside Precision Medicine - March 18th, 2024
- Global Genomics Industry Research 2024-2031: Rising Adoption of Personalized Medicines and Gene Therapies ... - PR Newswire - March 18th, 2024
- CAR T-Cell Therapy Successfully Used to Treat Brain Tumors - Inside Precision Medicine - March 18th, 2024
- Revolutionizing Wellness: The Power of Personalised Health Tech - AutoGPT - March 18th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- AI and predictive medicine: Recent advances - News-Medical.Net - March 10th, 2024
- Personalized medicine is coming, but who will have access to it? - AAMC - March 10th, 2024
- Why personalized medicine is a business trend to watch in 2024 - HealthLeaders Media - March 10th, 2024
- AI helps cardiologists deliver personalized healthcarebut there is still plenty of work to do - Cardiovascular Business - March 10th, 2024
- Q&A: How AI and wearable technologies are transforming medicine - EMS1.com - March 10th, 2024
- HealthTech Revolution: Wearables, AI, and the Personalized Future of Healthcare - GearBrain - March 10th, 2024
- Redefining Healthcare: The Rise of Personalized Medicine and the Shift from Conventional Care - Medriva - March 10th, 2024
- Dr Kalinsky on Unanswered Questions Regarding Genomic Testing in HR+ Breast Cancer - OncLive - March 10th, 2024
- Chemotherapy Plus High Doses of Radiation Effective for Treating Non-Small Cell Lung Cancer - Inside Precision Medicine - January 17th, 2024
- It's Time to Fully Embrace Precision Medicine's Promise in Pediatrics - Healthcare Innovation - January 17th, 2024
- Special Report: Radiation Oncology Takeaways from RSNA23 - Imaging Technology News - January 17th, 2024
- Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing ... - PR Newswire - January 17th, 2024
- Simulations of the human body and advanced data promise more personalized medical treatment - Medical Xpress - January 17th, 2024
- United States Single Cell Genomics and Proteomics Growth Opportunities: The Integration of Multi-Omics Data to Drive ... - PR Newswire - January 17th, 2024
- Advances Usher In Era of Personalized Treatment for Obesity - Gastroenterology & Endoscopy News - January 17th, 2024
- Unveiling the Reality of Personalized Medicine: Yale Study Highlights Limitations in Current Predictive Models - Medriva - January 17th, 2024
- Digital Twins: The Future of Personalized Healthcare - BNN Breaking - January 17th, 2024
- Healthcare in 2024: A Vision of the Future | Future of Healthcare Predictions - Medriva - January 17th, 2024
- Utilization of the microbiome in personalized medicine - Nature.com - December 22nd, 2023
- Focusing on Women's Health - Inside Precision Medicine - December 22nd, 2023
- Revolutionizing Healthcare: Innovations in Regenerative Medicine Offer Hope - Inside Precision Medicine - December 22nd, 2023
- AI in Genomics Market Predicted to Grow at CAGR of 40.6% by 2031, with Revenue $9.8 Billion - PharmiWeb.com - December 22nd, 2023
- Innovative Technologies Transforming Cancer Treatment - BNN Breaking - December 22nd, 2023
- Antisense Oligonucleotides Industry Poised to Reach US$ 5519.6 Million by 2033-FMI Projection - PharmiWeb.com - December 22nd, 2023
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022